113 Botanicals Limited encompasses our CBD wellness range and our research and development entity: 113 Therapeutics.

113 Therapeutics combines our expertise in botanical extraction engineering and medicinal biotech process design with ground-breaking new research.

Our licensed laboratory research, onsite at The University of Sussex, and our collaborations with leading, international organisations including Bedrocan and Lab Ofichem, uniquely places us to create new innovations in the field of cannabis-based pharmaceutical medicines.

Our mission is to develop high quality CBPMs and innovative routes of administration, all with a focus on the highest standards, ease of use, ease of access and affordability.